Navigation Links
Aamir Rules Out Apologising For Remarks On Narmada Issue

Bollywood actor Aamir Khan, whose latest flick 'Fanaa' could not be released in Gujarat following sharp reaction to his stand on Narmada dam oustees, today ruled out apologising for his remarks even if it hampers his career in the industry.//

Addressing the media at his Bandra residence, the actor said there was no question of tendering apology to anyone. After all, he had said what the Supreme Court had earlier stated in its order, Khan asserted.

Asked whether his stand on the issue could hamper his career, he said "Maybe it will. Perhaps producers will be apprehensive of signing me on." "I welcome the Supreme Court stand on the release of Fanaa, asking the authorities to provide security to theatres wanting to screen the film. It is now upto the BJP Youth Wing workers to decide whether or not they want to respect the Supreme Court, freedom of speech and democracy," Khan said.

"I would only like to appeal to the people of Gujarat not to be fooled by all the propaganda against me. They only have to look me in the eyes to realise the kind of love I have in my heart for Gujarat and its people." Khan seemed disappointed at the kind of support he had received from the industry. "It is upto the film industry to decide what it's future course of action is. The whole nation is watching to see whether it takes a concrete step, or whether it takes a weak step or nothing at all," he added.

Source:PTI News
'"/>




Page: 1

Related medicine news :

1. Chennai Students Protest Against Aamir Khan for Endorsing Coke
2. Key step forward on International Health Rules
3. U.S. To Tighten Sick Passenger, Quarantine Rules
4. Novel Rules And Regulations For Cardiovascular Catheterization Labs.
5. FDA to Revise Herpes Test Rules in the US
6. Aussie Rules, High on Football Injuries
7. Lady Patient Died after Hospital Turned Inhospitable, Rules Sheriff
8. WHO Rules Out Human Transmission Of Bird Flu In 4 Cases
9. NICE Setback Rules for Pfizers Inhaled Insulin
10. Japanese Court Rules In Patients Favour Over Hepatitis C Scandal
11. British Court Rules In Favour of Free Treatment For Prisoners With HIV
Post Your Comments:
(Date:10/10/2008)...n (a) levels boost cardiovascular disease risk fo...y News) -- If you,re worried about reducing your r...at you should quit smoking, eat a healthful diet, ...eck, and make sure your cholesterol levels aren,t ...ein (a) levels are? , Well, if you don,t have ...
(Date:10/10/2008)...mpany committed to helping people address health n.../ -- In these troubling,economic times, people may... may feel that they don,t have the money to visit ...a survey by the National Association of,Insurance ... -- Twenty-two percent of Americans say that they ...
(Date:10/10/2008)...Oct. 10 /PRNewswire/ -- Do you think that the blin...d town? Attend the October,17 open house at the Vi...ion Impaired, and see how instructors there empowe...ve, fulfilling lives through non-visual,techniques...1 Azalea Avenue, is holding an open house to,celeb...
(Date:10/10/2008)...omy serving as tipping point for behavior change, ...-- More than half of,Americans (51 percent) believ...are system, but major changes are needed, accordin...urvey was released today by the,Employee Benefit R...tes,Inc., and was underwritten by the Principal Fi...
Breaking Medicine News(10 mins):Health News:Little-Known Fat Can Be a Heartbreaker 2Health News:Little-Known Fat Can Be a Heartbreaker 3Health News:Healthcare Resources Available in Difficult Times 2Health News:Healthcare Resources Available in Difficult Times 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3
...diabetes, and arthritis are among a variety of aut... of white blood cell, called the immune regulatory...s malfunction is when a mutation in the FOXP3 gene...In a new study published online this week in the P...
...cted on mice shows that more copper in everyday di...ducted by scientists at the University of Louisvil...esearch Center. Their studies show that giving co...ress on their over-worked hearts by preventing hea...
...cted by American Academy of Neurology finds that e...providing short-term pain relief for lower back pa...long-term pain relief. To develop the guideline, ...c studies on the topic. According to the guidelin...
...time. An extra hour to enjoy life outside. An extr.../ . What should we do when the clock jukes and ji...aves that regulate our sleep? It’s bad enough for... concept. What about kids, who will want to squeez...
Other Medicine News:Health News:Researchers Discover New Molecular Path to Fight Autoimmune Diseases 2Health News:Use Daylight-saving Change to Practice Healthy Sleep Habits 2
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical In...panded clinical data and new nonclinical data,demo... may be broadly,applicable in DNA- and protein-bas...ancer vaccines. Alain P. Rolland, Pharm.D., Ph.D.,...ent, will present the data today,Wednesday, Octob...
(Date:10/7/2008)... Study evaluates the efficacy of new device for de...issed during colonoscopy, ORLANDO, Fla., Oct. 7 /...terology Annual Scientific Meeting in Orlando (ACG..., MD presented results from a,multi-institutional ...Third,Eye(R) Retroscope(R), a new device that is d...
(Date:10/7/2008)... Study Showed Larazotide Acetate Prevented Immun...n Patients with Celiac Disease, Additional Data In...isease, ORLANDO, Fla., Oct. 7 /- Alb...two clinical studies this week at the American,Col...fic Meeting. Data from,study CLIN 1001-004, the fi...
(Date:10/7/2008)... - Data Presented Today at ACG Annual Sci...ire-FirstCall/ -- Ironwood,Pharmaceuticals, Inc. (...Inc. (NYSE: FRX ) today announced the presentatio...lotide,s safety and efficacy in 420 patients with,.... Analysis of the data,indicates that once- daily ...
Breaking Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 2Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 3Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 4Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 5Alba Therapeutics Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5Your belly fat could be making you hungrier 17023 1Your belly fat could be making you hungrier 17023 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 1GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 2GHX Introduces NuVia 28TM 29 an Artificial Intelligence based Technology That Enables a New Approach to Content Management for Healthcare Providers 17020 3The Miracle of Funding by State and Local Pension Plans 17016 1The Miracle of Funding by State and Local Pension Plans 17016 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 1AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 2AegisLiving Partners With Technogym USA to Enhance Wellness Throughout Its Communities 17012 3
...ewswire/ -- A new study,demonstrated that the acti...cg twice a day, may improve symptom relief rates i...pation (IBS-C). These,results were presented as a ...argest annual international meeting of digestive d...eiving lubiprostone were nearly,twice as likely to...
...007 - Results from phase III,clinical trials and f...t the 16th Congress of the European Academy of,Der...ghted the,efficacy and safety profile of alitretin...atients with severe refractory chronic,hand eczema...vere Chronic Hand,Eczema (CHE) refractory or unres...
Other Medicine Technology:New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 2New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 3New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 4New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 5New Study Demonstrates that Lubiprostone May Improve Symptom Relief,Rates in Adults with Irritable Bowel Syndrome with Constipation,(IBS-C) 6Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5
Portable shields for your safety and convenience.
Full-Height Radiation Barriers provide full-body shielding and reduce eye strain during extended procedures.
0.5 mm Pb protection with height-adjustment for patient and practitioner. Measures 18"L x 24"W adjusts 36" to 56" in height at lowest height (36") bottom hem remains 12" from floor. 5 leg base for ma
Ball-and-socket center mount can rotate 360, allowing them to be turned hoirzontally, vertically, or at any angle. Very versatile! Available with or without torso placement contour cutout and in thre
Medicine Products: